We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$250M
AUM Growth
-$3.21M
(-1.3%)
Cap. Flow
-$9.77M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
39.19%
Holding
61
New
2
Increased
2
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$2.26M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$1.81M |
| 3 |
Analog Devices
ADI
|
+$1.76M |
| 4 |
New York Times
NYT
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.97M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$2.68M |
| 3 |
Procter & Gamble
PG
|
+$2.53M |
| 4 |
IPG Photonics
IPGP
|
+$1.81M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$1.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.32% |
| 2 | Industrials | 19.26% |
| 3 | Technology | 18.3% |
| 4 | Communication Services | 9.29% |
| 5 | Financials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Canadian National Railway
CNI
$78.3B
| $746K | 0.3% |
9,125
| – | – |
|
|
CDK
52
DELISTED
CDK Global, Inc.
CDK
| $705K | 0.28% |
10,833
| – | – |
|
53
Novartis
NVS
$293B
| $704K | 0.28% |
10,396
| – | – |
|
|
WIRE
54
DELISTED
Encore Wire Corp
WIRE
| $617K | 0.25% |
13,000
| – | – |
|
55
Chevron
CVX
$373B
| $313K | 0.13% |
2,472
| – | – |
|
56
Adient
ADNT
$1.55B
| – | – |
-11,357
| Closed | -$679K |
|
|
57
Bristol-Myers Squibb
BMY
$124B
| – | – |
-23,200
| Closed | -$1.47M |
|
|
58
CVS Health
CVS
$137B
| – | – |
-47,705
| Closed | -$2.97M |
|
59
iShares Core S&P 500 ETF
IVV
$881B
| – | – |
-800
| Closed | -$212K |
|
60
Coca-Cola
KO
$351B
| – | – |
-8,131
| Closed | -$353K |
|
|
WBA
61
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-40,900
| Closed | -$2.68M |
|
Similar funds
RC
TTSTC
KFAS
KGAMU
RIS
AMG
BWP
MC
Chad R. Baker's Q2 2018 Portfolio in Review
As of Q2 2018, Chad R. Baker held 61 positions worth $250M, down 1.3% from $253M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Chad R. Baker withdrew a net $9.77M in Q2 2018, closing 6 positions and reducing 7 holdings. Its most notable exit was CVS Health, an estimated $2.97M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.
Against the trend, Chad R. Baker opened a new position in Teladoc Health worth $2.69M.
- Chad R. Baker's largest Q2 2018 buy was Teladoc Health: 46,345 shares worth $2.69M.
- Chad R. Baker added most to Xilinx Inc in Q2 2018, an estimated $1.81M increase.
- Chad R. Baker's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $2.53M.
- Chad R. Baker fully exited CVS Health in Q2 2018, selling an estimated $2.97M.
- Chad R. Baker's ten largest holdings make up 39% of its $250M portfolio in Q2 2018.
- Chad R. Baker opened 2 new positions and closed 6 in Q2 2018.
- Chad R. Baker's portfolio value fell 1.3% quarter-over-quarter to $250M.
Based on Chad R. Baker's 13F filing for Q2 2018, filed 13 Aug 2018.